3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
35
Phase 3
7
Phase 1/2
6
Phase NA
5
Phase 1
4
Phase EARLY_PHASE1
1
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Rhabdoid Tumor
2
Medulloblastoma
2
Ependymoma
2
Brain Neoplasms
2
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neurotoxicity Syndromes
1
Muscle Invasive Bladder Urothelial Carcinoma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Leukemia, Large Granular Lymphocytic
1
Central Nervous System Neoplasms
1
Burkitt Lymphoma
1
Interventions
Cyclophosphamide
4
Rituximab
3
Vincristine
2
Prednisone
2
Peripheral Blood Stem Cell Transplantation
2
Magnetic Resonance Spectroscopy
2
Immunotherapy, Adoptive
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
Etoposide
2
Doxorubicin
2
tisagenlecleucel
1
pegylated granulocyte colony-stimulating factor, human
1
pegfilgrastim
1
oblimersen
1
ibritumomab tiuxetan
1
duvelisib
1
Surveys and Questionnaires
1
Sugars
1
Specimen Handling
1
Radiation
1
Pemetrexed
1
Nivolumab
1
NVP-BKM120
1
Microarray Analysis
1
Methotrexate
1
Loratadine
1
Leukapheresis
1
Immunohistochemistry
1
Gene Expression Profiling
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Lymphoma, Large B-Cell, Diffuse
×
Methotrexate
×
Clear all
NCT01760226
2025-10-14
DA-EPOCH-R
Baylor College of Medicine
Phase EARLY_PHASE1
Completed
4 enrolled